Tenaya Therapeutics Inc (NASDAQ: TNYA) on Monday, plunged -3.75% from the previous trading day, before settling in for the closing price of $0.50. Within the past 52 weeks, TNYA’s price has moved between $0.39 and $4.96.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 45.89%. With a float of $134.09 million, this company’s outstanding shares have now reached $162.58 million.
The firm has a total of 97 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Tenaya Therapeutics Inc (TNYA) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Tenaya Therapeutics Inc is 17.52%, while institutional ownership is 20.39%. The most recent insider transaction that took place on Mar 10 ’25, was worth 1,336. In this transaction SVP, Finance of this company sold 2,482 shares at a rate of $0.54, taking the stock ownership to the 99,690 shares. Before that another transaction happened on Mar 10 ’25, when Company’s Chief Medical Officer sold 7,398 for $0.54, making the entire transaction worth $3,983. This insider now owns 174,793 shares in total.
Tenaya Therapeutics Inc (TNYA) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 45.89% per share during the next fiscal year.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Trading Performance Indicators
Tenaya Therapeutics Inc (TNYA) is currently performing well based on its current performance indicators. A quick ratio of 4.22 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.31, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Tenaya Therapeutics Inc (TNYA)
Analysing the last 5-days average volume posted by the [Tenaya Therapeutics Inc, TNYA], we can find that recorded value of 4.0 million was better than the volume posted last year of 3.35 million. As of the previous 9 days, the stock’s Stochastic %D was 10.08%. Additionally, its Average True Range was 0.08.
During the past 100 days, Tenaya Therapeutics Inc’s (TNYA) raw stochastic average was set at 2.38%, which indicates a significant decrease from 13.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 93.54% in the past 14 days, which was lower than the 199.96% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8146, while its 200-day Moving Average is $2.0347. Now, the first resistance to watch is $0.5221. This is followed by the second major resistance level at $0.5641. The third major resistance level sits at $0.6038. If the price goes on to break the first support level at $0.4404, it is likely to go to the next support level at $0.4007. Should the price break the second support level, the third support level stands at $0.3587.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Key Stats
Market capitalization of the company is 78.06 million based on 87,583K outstanding shares. Right now, sales total 0 K and income totals -111,130 K. The company made 0 K in profit during its latest quarter, and -23,840 K in sales during its previous quarter.
